These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
555 related articles for article (PubMed ID: 18447405)
1. Potential adverse effects of bronchodilators in the treatment of airways obstruction in older people: recommendations for prescribing. Gupta P; O'Mahony MS Drugs Aging; 2008; 25(5):415-43. PubMed ID: 18447405 [TBL] [Abstract][Full Text] [Related]
2. Asthma medications and their potential adverse effects in the elderly: recommendations for prescribing. Newnham DM Drug Saf; 2001; 24(14):1065-80. PubMed ID: 11735662 [TBL] [Abstract][Full Text] [Related]
4. Anti-cholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease. McCrory DC; Brown CD Cochrane Database Syst Rev; 2002; 2003(4):CD003900. PubMed ID: 12519615 [TBL] [Abstract][Full Text] [Related]
5. A benefit-risk assessment of inhaled long-acting beta2-agonists in the management of obstructive pulmonary disease. Sovani MP; Whale CI; Tattersfield AE Drug Saf; 2004; 27(10):689-715. PubMed ID: 15350154 [TBL] [Abstract][Full Text] [Related]
6. Overcoming gaps in the management of asthma in older patients: new insights. Barua P; O'Mahony MS Drugs Aging; 2005; 22(12):1029-59. PubMed ID: 16363886 [TBL] [Abstract][Full Text] [Related]
7. Is combination therapy with inhaled anticholinergics and beta2-adrenoceptor agonists justified for chronic obstructive pulmonary disease? Reddy CB; Kanner RE Drugs Aging; 2007; 24(8):615-28. PubMed ID: 17702532 [TBL] [Abstract][Full Text] [Related]
9. Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute asthma in children. Griffiths B; Ducharme FM Cochrane Database Syst Rev; 2013 Aug; (8):CD000060. PubMed ID: 23966133 [TBL] [Abstract][Full Text] [Related]
10. Long-acting beta2 agonists in the management of stable chronic obstructive pulmonary disease. Cazzola M; Donner CF Drugs; 2000 Aug; 60(2):307-20. PubMed ID: 10983735 [TBL] [Abstract][Full Text] [Related]
11. Long-acting beta2-agonists (LABA) in chronic obstructive pulmonary disease: efficacy and safety. Rossi A; Khirani S; Cazzola M Int J Chron Obstruct Pulmon Dis; 2008; 3(4):521-9. PubMed ID: 19281071 [TBL] [Abstract][Full Text] [Related]
12. Bronchodilator combination therapy for the treatment of chronic obstructive pulmonary disease. Sethi S; Cote C Curr Clin Pharmacol; 2011 Feb; 6(1):48-61. PubMed ID: 21235463 [TBL] [Abstract][Full Text] [Related]
13. Comparison of inhaled long-acting β-agonist and anticholinergic effectiveness in older patients with chronic obstructive pulmonary disease: a cohort study. Gershon A; Croxford R; To T; Stanbrook MB; Upshur R; Sanchez-Romeu P; Stukel T Ann Intern Med; 2011 May; 154(9):583-92. PubMed ID: 21536937 [TBL] [Abstract][Full Text] [Related]
14. Systematic review of clinical outcomes in chronic obstructive pulmonary disease: beta-agonist use compared with anticholinergics and inhaled corticosteroids. Salpeter SR; Buckley NS Clin Rev Allergy Immunol; 2006; 31(2-3):219-30. PubMed ID: 17085795 [TBL] [Abstract][Full Text] [Related]
15. Bronchodilators in COPD: impact of beta-agonists and anticholinergics on severe exacerbations and mortality. Salpeter SR Int J Chron Obstruct Pulmon Dis; 2007; 2(1):11-8. PubMed ID: 18044061 [TBL] [Abstract][Full Text] [Related]
16. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD. Keam SJ; Keating GM Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163 [TBL] [Abstract][Full Text] [Related]
17. The role of tiotropium bromide, a long-acting anticholinergic bronchodilator, in the management of COPD. Saberi F; O'Donnell DE Treat Respir Med; 2005; 4(4):275-81. PubMed ID: 16086600 [TBL] [Abstract][Full Text] [Related]